MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 39 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28 | -47.2% | 214,337 | +46.7% | 0.00% | – |
| Q2 2023 | $53 | -34.6% | 146,100 | -15.0% | 0.00% | – |
| Q1 2023 | $81 | +32.8% | 171,929 | +42.0% | 0.00% | – |
| Q4 2022 | $61 | -99.7% | 121,096 | +258.3% | 0.00% | – |
| Q3 2022 | $21,000 | -95.6% | 33,800 | -94.5% | 0.00% | -100.0% |
| Q2 2021 | $472,000 | +221.1% | 609,152 | +333.9% | 0.00% | – |
| Q1 2021 | $147,000 | -91.1% | 140,403 | -88.5% | 0.00% | -100.0% |
| Q4 2020 | $1,658,000 | +704.9% | 1,219,162 | +356.6% | 0.00% | – |
| Q2 2020 | $206,000 | -66.5% | 267,000 | -73.9% | 0.00% | -100.0% |
| Q1 2020 | $615,000 | -9.0% | 1,024,300 | +243.8% | 0.00% | 0.0% |
| Q4 2019 | $676,000 | +144.9% | 297,942 | +17.8% | 0.00% | – |
| Q1 2019 | $276,000 | +122.6% | 253,000 | +87.5% | 0.00% | – |
| Q3 2018 | $124,000 | +785.7% | 134,900 | +325.6% | 0.00% | – |
| Q2 2018 | $14,000 | – | 31,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 1,429,532 | $1,944,000 | 0.61% |
| Boxer Capital, LLC | 11,478,634 | $15,611,000 | 0.50% |
| Vivo Capital, LLC | 6,451,612 | $8,774,000 | 0.39% |
| Philadelphia Financial Management of San Francisco, LLC | 740,861 | $1,008,000 | 0.26% |
| DCF Advisers, LLC | 305,299 | $415,000 | 0.17% |
| Main Street Financial Solutions, LLC | 400,826 | $545,000 | 0.11% |
| Platform Technology Partners | 158,660 | $216,000 | 0.10% |
| STALEY CAPITAL ADVISERS INC | 600,000 | $816,000 | 0.05% |
| MONECO Advisors, LLC | 50,000 | $81,000 | 0.04% |
| CCG WEALTH MANAGEMENT, LLC | 30,000 | $41,000 | 0.04% |